Alhijama Related to the Decrease of Systolic Blood Pres- sure in Hypertensive Patients: Preliminary Study

Abstract

Some patients with Non-Comunicable Diseases (NCD) like hyperten- sion receive hijamah in addition to community health center treatment to support conventional treatment and maintain a stable blood pressure [1][2] Few studies have shown that hijamah lowers blood pressure in hypertensive patients, thus more research is needed. Hypertension is common and has increased over the previous decade, worsened by rising healthcare expenses in Indonesia [3] [4] [5] [6] [7]. Most hypertensive patients are productive age [8], and their quality of life is affected [9], which is harmful to the patients, their families, and public health and community welfare [10] [11] [12]. This circumstance will disturb the resilience of a nation on a national scale, as the resilience of a nation is determined by its people, which is dependent on family resilience and individual resilience [13] [12]. Hypertension is on the rise [6] [5] [7], and most patients are unaware [14]. They are youths to seniors [8] and unaware of hypertension problems [15]. They only realized they had high blood pressure after an exam [16] and CERDIK instruc- tion [17], with some taking additional steps [18]. Many hypertension sufferers use complementary methods like hijama. Some have been proven elsewhere, but clinical laboratory approaches to testing effec- tiveness are rare in Indonesia. This initial stage will verify its effects for lowering blood pressure in hypertensive individuals, allowing clinical laboratory verifica- tion. This should explain hijama therapy's success scientifically.